FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097444417> ?p ?o ?g. }

• W3097444417 endingPage "11109" @default.
• W3097444417 startingPage "11097" @default.
• W3097444417 abstract "Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy affecting the oral cavity and is associated with severe morbidity and high mortality. 1, 6-O, O-Diacetylbritannilactone (OODBL) isolated from the medicinal herb of Inula britannica has various biological activities such as anti-inflammation and anti-cancer. However, the effect of OODBL on OSCC progression remains unclear. Here, we were interested in the function of OODBL in the development of OSCC.The effect of OODBL on OSCC progression was analyzed by MTT assays, colony formation assays, transwell assays, apoptosis analysis, cell cycle analysis, and in vivo tumorigenicity analysis. The mechanism investigation was performed by qPCR assays, Western blot analysis, and luciferase reporter gene assays.We found that OODBL inhibits the proliferation of OSCC cells in vitro. Moreover, the migration and invasion were attenuated by OODBL treatment in the OSCC cells. OODBL arrested cells at the G0/G1 phase and induced cell apoptosis. OODBL was able to up-regulate the expression of LXRα, ABCA1, and ABCG1 in the system. In addition, OODBL activated LXRα/ABCA1 signaling by targeting miR-1247-3p. Furthermore, the expression levels of cytochrome c in the cytoplasm, cleaved caspase-9, and cleaved caspase-3 were dose-dependently reduced by OODBL. Besides, OODBL increased the expression ratio of Bax to Bcl-2. Moreover, OODBL repressed tumor growth of OSCC cells in vivo.Thus, we conclude that OODBL inhibits OSCC progression by modulating miR-1247-3p/LXRα/ABCA1 signaling. Our finding provides new insights into the mechanism by which OODBL exerts potent anti-tumor activity against OSCC. OODBL may be a potential anti-tumor candidate, providing a novel clinical treatment strategy of OSCC." @default.
• W3097444417 created "2020-11-09" @default.
• W3097444417 creator A5009318195 @default.
• W3097444417 creator A5018784137 @default.
• W3097444417 creator A5031315906 @default.
• W3097444417 creator A5076042378 @default.
• W3097444417 creator A5090566169 @default.
• W3097444417 date "2020-10-01" @default.
• W3097444417 modified "2023-09-25" @default.
• W3097444417 title "<p>1, 6-O, O-Diacetylbritannilactone from Inula britannica Induces Anti-Tumor Effect on Oral Squamous Cell Carcinoma via miR-1247-3p/LXRα/ABCA1 Signaling</p>" @default.
• W3097444417 cites W1516666861 @default.
• W3097444417 cites W1522908534 @default.
• W3097444417 cites W1798164203 @default.
• W3097444417 cites W1915193919 @default.
• W3097444417 cites W1978588762 @default.
• W3097444417 cites W1978978455 @default.
• W3097444417 cites W1984205398 @default.
• W3097444417 cites W1984792991 @default.
• W3097444417 cites W1985275037 @default.
• W3097444417 cites W1994682335 @default.
• W3097444417 cites W2001195644 @default.
• W3097444417 cites W2010850711 @default.
• W3097444417 cites W2021450676 @default.
• W3097444417 cites W2036967029 @default.
• W3097444417 cites W2041463050 @default.
• W3097444417 cites W2050313212 @default.
• W3097444417 cites W2086853589 @default.
• W3097444417 cites W2106787323 @default.
• W3097444417 cites W2109068305 @default.
• W3097444417 cites W2109227959 @default.
• W3097444417 cites W2122935174 @default.
• W3097444417 cites W2145444543 @default.
• W3097444417 cites W2158618774 @default.
• W3097444417 cites W2163512830 @default.
• W3097444417 cites W2166526596 @default.
• W3097444417 cites W2178648611 @default.
• W3097444417 cites W2254993519 @default.
• W3097444417 cites W2307905122 @default.
• W3097444417 cites W2398214439 @default.
• W3097444417 cites W2413193942 @default.
• W3097444417 cites W2414196293 @default.
• W3097444417 cites W2530842562 @default.
• W3097444417 cites W2531068218 @default.
• W3097444417 cites W2564021620 @default.
• W3097444417 cites W2588025094 @default.
• W3097444417 cites W2607810156 @default.
• W3097444417 cites W2621306873 @default.
• W3097444417 cites W2670196195 @default.
• W3097444417 cites W2741253816 @default.
• W3097444417 cites W2744969389 @default.
• W3097444417 cites W2767120861 @default.
• W3097444417 cites W2767341778 @default.
• W3097444417 cites W2774702058 @default.
• W3097444417 cites W2779186169 @default.
• W3097444417 cites W2783562764 @default.
• W3097444417 cites W2784058110 @default.
• W3097444417 cites W2789384672 @default.
• W3097444417 cites W2789702646 @default.
• W3097444417 cites W2793560975 @default.
• W3097444417 cites W2794361580 @default.
• W3097444417 cites W2795936307 @default.
• W3097444417 cites W2890316895 @default.
• W3097444417 cites W2891041575 @default.
• W3097444417 cites W2895618137 @default.
• W3097444417 cites W2896115148 @default.
• W3097444417 cites W2900112088 @default.
• W3097444417 cites W2904847308 @default.
• W3097444417 cites W2913310716 @default.
• W3097444417 cites W2928743113 @default.
• W3097444417 cites W2938824619 @default.
• W3097444417 cites W2953637255 @default.
• W3097444417 cites W2955521507 @default.
• W3097444417 cites W2972409668 @default.
• W3097444417 cites W2978058926 @default.
• W3097444417 cites W3008020747 @default.
• W3097444417 cites W3015175848 @default.
• W3097444417 cites W3025352828 @default.
• W3097444417 cites W3025518023 @default.
• W3097444417 doi "https://doi.org/10.2147/ott.s263014" @default.
• W3097444417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7605651" @default.
• W3097444417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33149621" @default.
• W3097444417 hasPublicationYear "2020" @default.
• W3097444417 type Work @default.
• W3097444417 sameAs 3097444417 @default.
• W3097444417 citedByCount "4" @default.
• W3097444417 countsByYear W30974444172021 @default.
• W3097444417 countsByYear W30974444172022 @default.
• W3097444417 countsByYear W30974444172023 @default.
• W3097444417 crossrefType "journal-article" @default.
• W3097444417 hasAuthorship W3097444417A5009318195 @default.
• W3097444417 hasAuthorship W3097444417A5018784137 @default.
• W3097444417 hasAuthorship W3097444417A5031315906 @default.
• W3097444417 hasAuthorship W3097444417A5076042378 @default.
• W3097444417 hasAuthorship W3097444417A5090566169 @default.
• W3097444417 hasBestOaLocation W30974444171 @default.
• W3097444417 hasConcept C104317684 @default.
• W3097444417 hasConcept C149011108 @default.
• W3097444417 hasConcept C1491633281 @default.

• next